PRIOR-Trauma: Preoxygenation With High-flow Nasal Oxygen in Adult Trauma Patients During Rapid Sequence Induction Anaesthesia

Sponsor
Karolinska University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04926337
Collaborator
(none)
300
1
19
15.8

Study Details

Study Description

Brief Summary

Previous studies investigating apnoea oxygenation has shown that delivering oxygen via a high flow can maintain adequate oxygen saturation levels in a patient for over 30 minutes.

It has recently been demonstrated, in several studies, that High Flow Nasal Oxygen (HFNO) used during preoxygenation in patients undergoing emergency surgery is at least equally effective as preoxygenation with standard tight fitting mask. Data from these recent studies investigating arterial oxygen saturation levels during rapid sequence induction anaesthesia have not been able to detect any difference between the two methods. The mean apnea time among the patients in the previous studies have been relatively short.

Patients suffering traumatic injuries could be more prone to desaturate during prolonged apnea due to being hemodynamic unstable or suffering injuries to the respiratory tract.

Based on the above, the aim is now to conduct a trial where trauma patients are preoxygenated with high flow nasal oxygen before anaesthetised with rapid sequence induction (RSI) technique. The trial is set to be a before-and-after study. During approximately 6 to 9 months data will be registered from trauma patients undergoing emergency anaesthesia where preoxygenation is performed according to standard rutin, with traditional facemask. During the coming six to nine months trauma patients undergoing emergency anaesthesia will be preoxygenated with high flow nasal oxygen. Data will be registered and compared to the data collected from the patients preoxygenated with facemark.

The general purpose of this project is to compare the preoxygenation technique based on HFNO with traditional preoxygenation with a tight fitting mask, with the main focus being oxygen saturation levels, during rapid sequence induction (RSI) intubation in trauma patients in need of immediate anaesthesia.

Condition or Disease Intervention/Treatment Phase
  • Device: Tight Fitting Facemask
  • Device: High Flow Nasal Oxygen (HFNO)

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Preoxygenation With High-flow Nasal Oxygen in Comparison to Standard Face Mask in Adult Trauma Patients During Rapid Sequence Induction Anesthesia- a Prospective, Non-randomized, Before-and-after Study
Actual Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Tight fitting facemask

Preoxygenation with tight facemask, 100% oxygen.

Device: Tight Fitting Facemask
Preoxygenation with tight facemask, 10 L/min, 100% oxygen.

High flow nasal oxygen

Preoxygenation with high flow nasal oxygen, 100% oxygen

Device: High Flow Nasal Oxygen (HFNO)
Preoxygenation with high flow nasal oxygen, 40-70 L/min, 100% oxygen.

Outcome Measures

Primary Outcome Measures

  1. Number of patients with a peripheral oxygen saturation (SpO2) below 93% [From start of anaesthesia until 1 minute after tracheal intubation.]

    Compare the number of patients with a peripheral oxygen saturation (SpO2) below 93% from induction of anesthesia (when induction drug is administered) until one minute after intubation between the group preoxygenated using HFNO and the group preoxygenated with traditional tight-fitting mask.

Secondary Outcome Measures

  1. Lowest median SpO2. [From start of anaesthesia until 1 minute after tracheal intubation.]

    Lowest median SpO2 during preoxygenation using HFNO compared to traditional preoxygenation from when first anesthetic drug is administered until 1 minute after intubation

  2. End tidal gas levels [At the first breath after tracheal intubation.]

    Difference in levels of ETO2 and ETCO2 in the first breath after intubation with HFNO oxygenation compared to traditional pre-oxygenation.

  3. Time span from start of preoxygenation until intubation. [Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.]

    Compare the time span from start of preoxygenation until intubation between the HFNO group and the group with traditional preoxygenation.

  4. Time span from entering trauma room until intubation. [Could vary depending on patient and trauma, from a couple of minutes up to an hour.]

    Time span from when the patient enters the trauma room until intubation in the HFNO group compared to the group with traditional preoxygenation.

  5. Difficulties with induction of anaesthesia [Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.]

    Compare the perceived difficulties during induction of anaesthesia between the HFNO technique and traditional preoxygenation, for example tolerance to mask or nasal cannula

  6. Frequency of complications [Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.]

    Frequency of complications (aspiration, signs of intraabdominal/intracranial gas, difficulties intubating the trachea, hypotension) in the HFNO group compared to the group preoxygenated with traditional facemask.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 1 Adult, ≥18 years old

  • 2 Level 1 trauma with patients in need of emergency anaesthesia before leaving the trauma unit (trauma room or nearby operating theatre).

Exclusion Criteria:
  • 1 Patients with or with risk of skull or facial injuries where application of nasal cannula is decided to be avoided by the trauma team.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska University Hospital Solna Stockholm Sweden SE-17176

Sponsors and Collaborators

  • Karolinska University Hospital

Investigators

  • Principal Investigator: Malin Jonsson Fagerlund, Karolinska University Hospital and Karolinska Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Malin Jonsson Fagerlund, Senior consultant, Associate Professor, Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT04926337
Other Study ID Numbers:
  • PRIOR-Trauma
First Posted:
Jun 15, 2021
Last Update Posted:
Apr 4, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2022